Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-κB Signaling Pathway

por Zhang, Jian-ning, Ma, Yang, Wei, Xi-yan, Liu, Ke-yin, Wang, Hao, Han, Hui, Cui, Yi, Zhang, Ming-xiang, Qin, Wei-dong
Publicado 2019